Literature DB >> 640738

Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes.

P K Peterson, B J Wilkinson, Y Kim, D Schmeling, P G Quie.   

Abstract

In previous studies, encapsulated Staphylococcus aureus strains have been shown to resist phagocytosis. In this investigation, the nature of the interference with phagocytosis by human polymorphonuclear leukocytes was examined by studying the opsonization of two pairs of unencapsulated (Smith compact and M variant) and encapsulated (Smith diffuse and M) S. aureus strains. The uptake of [3H]glycine-labeled bacteria by normal leukocytes was quantitatively measured after incubation of bacteria in pooled serum, C2-deficient serum, immunoglobulin-deficient serum, and serum from a rabbit immunized with S. aureus M. The presence of a capsule was found to interfere with opsonization by both the classical and alternative pathways of complement as well as by heat-stable opsonic factors in nonimmune human serum. This interference was significantly greater in the case of the S. aureus M strain than in the case of the Smith diffuse strain. The only effective opsonic source for S. aureus M was immune rabbit serum. It is proposed that encapsulation of S. aureus strains interferes with phagocytosis by preventing effective bacterial opsonization.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 640738      PMCID: PMC422283          DOI: 10.1128/iai.19.3.943-949.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

Review 1.  Phagocytosis: recognition and ingestion.

Authors:  T P Stossel
Journal:  Semin Hematol       Date:  1975-01       Impact factor: 3.851

2.  Effect of protein A on staphylococcal opsonization.

Authors:  P K Peterson; J Verhoef; L D Sabath; P G Quie
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

3.  Inherited deficiency of the second component of complement (C2) with membranoproliferative glomerulonephritis.

Authors:  Y Kim; P S Friend; I G Dresner; E J Yunis; A F Michael
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

4.  Effects of staphylococcal protein A on heat labile opsonins.

Authors:  A Forsgren; P G Quie
Journal:  J Immunol       Date:  1974-03       Impact factor: 5.422

5.  Autolysis of microbial cells: salt activation of autolytic enzymes in a mutant of Staphylococcus aureus.

Authors:  R W Gilpin; A N Chatterjee; F E Young
Journal:  J Bacteriol       Date:  1972-07       Impact factor: 3.490

6.  Capsule production and virulence among strains of Staphylococcus aureus.

Authors:  B B Wiley; N H Maverakis
Journal:  Ann N Y Acad Sci       Date:  1974-07-31       Impact factor: 5.691

7.  Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains.

Authors:  J Verhoef; P Peterson; Y Kim; L D Sabath; P G Quie
Journal:  Immunology       Date:  1977-08       Impact factor: 7.397

8.  Kinetics of staphylococcal opsonization, attachment, ingestion and killing by human polymorphonuclear leukocytes: a quantitative assay using [3H]thymidine labeled bacteria.

Authors:  J Verhoef; P K Peterson; P G Quie
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

9.  Influence of a deficiency of the second component of complement on the bactericidal activity of neutrophils in vitro.

Authors:  J E Repine; C C Clawson; P S Friend
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

10.  Kinetics of phagocytosis and bacterial killing by human polymorphonuclear leukocytes and monocytes.

Authors:  P K Peterson; J Verhoef; D Schmeling; P G Quie
Journal:  J Infect Dis       Date:  1977-10       Impact factor: 5.226

View more
  61 in total

1.  Promoter analysis of the cap8 operon, involved in type 8 capsular polysaccharide production in Staphylococcus aureus.

Authors:  S Ouyang; S Sau; C Y Lee
Journal:  J Bacteriol       Date:  1999-04       Impact factor: 3.490

2.  Staphylococcus aureus cell surface: capsule as a barrier to bacteriophage adsorption.

Authors:  B J Wilkinson; K M Holmes
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

3.  The role of staphylococcal polysaccharide microcapsule expression in septicemia and septic arthritis.

Authors:  I M Nilsson; J C Lee; T Bremell; C Rydén; A Tarkowski
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

4.  Multiple consecutive lavage samplings reveal greater burden of disease and provide direct access to the nontypeable Haemophilus influenzae biofilm in experimental otitis media.

Authors:  Magali Leroy; Howard Cabral; Marisol Figueira; Valérie Bouchet; Heather Huot; Sanjay Ram; Stephen I Pelton; Richard Goldstein
Journal:  Infect Immun       Date:  2007-05-21       Impact factor: 3.441

5.  MgrA activates expression of capsule genes, but not the α-toxin gene in experimental Staphylococcus aureus endocarditis.

Authors:  Ravi Kr Gupta; Jimena Alba; Yan Q Xiong; Arnold S Bayer; Chia Y Lee
Journal:  J Infect Dis       Date:  2013-07-30       Impact factor: 5.226

Review 6.  Envelope Structures of Gram-Positive Bacteria.

Authors:  Mithila Rajagopal; Suzanne Walker
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

7.  Chemical characterization and immunogenicity of capsular polysaccharide isolated from mucoid Staphylococcus aureus.

Authors:  J C Lee; F Michon; N E Perez; C A Hopkins; G B Pier
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

8.  Virulence of Staphylococcus aureus mutants altered in type 5 capsule production.

Authors:  A Albus; R D Arbeit; J C Lee
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

9.  Phagocytic killing of encapsulated and microencapsulated Staphylococcus aureus by human polymorphonuclear leukocytes.

Authors:  S Xu; R D Arbeit; J C Lee
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

10.  Role of fibronectin in human monocyte and macrophage bactericidal activity.

Authors:  R A Proctor; J A Textor; J M Vann; D F Mosher
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.